rs886043807
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PM2PM5PP3_StrongPP5
The NM_003742.4(ABCB11):c.1708G>T(p.Ala570Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,460,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A570V) has been classified as Likely pathogenic.
Frequency
Consequence
NM_003742.4 missense
Scores
Clinical Significance
Conservation
Publications
- progressive familial intrahepatic cholestasis type 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- benign recurrent intrahepatic cholestasis type 2Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ABCB11 | NM_003742.4 | c.1708G>T | p.Ala570Ser | missense_variant | Exon 15 of 28 | ENST00000650372.1 | NP_003733.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ABCB11 | ENST00000650372.1 | c.1708G>T | p.Ala570Ser | missense_variant | Exon 15 of 28 | NM_003742.4 | ENSP00000497931.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1460796Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 726714 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
This sequence change replaces alanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 570 of the ABCB11 protein (p.Ala570Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with progressive familial intrahepatic cholestasis, type 2 (PMID: 32808743). ClinVar contains an entry for this variant (Variation ID: 1484807). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ABCB11 protein function. This variant disrupts the p.Ala570 amino acid residue in ABCB11. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 15300568, 18395098, 26678486). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
not specified Uncertain:1
Variant summary: ABCB11 c.1708G>T (p.Ala570Ser) results in a conservative amino acid change located in the ABC transporter-like, ATP-binding domain (IPR003439) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 248406 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1708G>T has been reported in the literature as a biallelic genotype in at least one individual affected with Familial Intrahepatic Cholestasis (Li_2020). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. These data do not allow any conclusion about variant significance. However, a different substitution occuring at Ala570 has been classified as pathogenic within ClinVar (ID: 288100), suggesting this codon may be of clinical significance. The following publication has been ascertained in the context of this evaluation (PMID: 32808743). One ClinVar submitter has assessed this variant since 2014, and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Progressive familial intrahepatic cholestasis type 2 Uncertain:1
The p.Ala570Ser variant in ABCB11 has been reported in 1 individual with BSEP deficiency (PMID: 32808743), and has been identified in 0.0005% (6/1179290) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs886043807). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID: 1484807) and has been interpreted as likely pathogenic by Invitae and a variant of uncertain significance by Women's Health and Genetics/Laboratory Corporation of America, LabCorp. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. Two additional likely pathogenic/pathogenic variants, resulting in a different amino acid change at the same position, p.Ala570Thr and p.Ala570Val, have been reported in association with disease in ClinVar, slightly supporting that a change at this position may not be tolerated (Variation ID: 288100, 2680875). In summary, while there is some suspicion for a pathogenic role, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PP3_moderate, PM2_supporting, PM5 (Richards 2015). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at